A novel role for platelet secretion in angiogenesis: mediating bone marrow–derived cell mobilization and homing
Open Access
- 7 April 2011
- journal article
- Published by American Society of Hematology in Blood
- Vol. 117 (14), 3893-3902
- https://doi.org/10.1182/blood-2010-08-304808
Abstract
Angiogenesis alleviates hypoxic stress in ischemic tissues or during tumor progression. In addition to endothelial cell proliferation and migration, the angiogenic process requires bone marrow–derived cell (BMDC) recruitment to sites of neovascularization. However, the mechanism of communication between hypoxic tissues and the BM remains unknown. Using 2 models of hypoxia-induced angiogenesis (ischemic hindlimb surgery and subcutaneous tumor growth), we show that platelet infusion promotes BMDC mobilization into the circulation, BMDC recruitment into growing neovasculature, tumor vascularization, and blood flow restoration in ischemic limbs, whereas platelet depletion inhibits these effects. Thus, platelets are required for BMDC recruitment into ischemia-induced vasculature. Secretion of platelet α-granules, but neither dense granules nor platelet aggregation is crucial for BMDC homing and subsequent angiogenesis, as determined using VAMP-8−/−, Pearl, and integrin Beta 3−/− platelets. Finally, platelets sequester tumor-derived promoters of angiogenesis and BMDC mobilization, which are counterbalanced by the antiangiogenic factor thrombospondin-1. A lack of thrombospondin-1 in platelets leads to an imbalance in proangiogenic and antiangiogenic factors and accelerates tumor growth and vascularization. Our data demonstrate that platelets stimulate BMDC homing in a VAMP-8–dependent manner, revealing a previously unknown role for platelets as key mediators between hypoxic tissues and the bone marrow during angiogenesis.This publication has 50 references indexed in Scilit:
- Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cellsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences of the United States of America, 2009
- The angiogenic response is dictated by β3 integrin on bone marrow–derived cellsThe Journal of cell biology, 2008
- Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growthProceedings of the National Academy of Sciences of the United States of America, 2008
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationJournal of Bone and Joint Surgery, 2007
- Endobrevin/VAMP-8 Is the Primary v-SNARE for the Platelet Release ReactionMolecular Biology of the Cell, 2007
- Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytesNature Medicine, 2006
- Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivoThe Journal of Experimental Medicine, 2006